Arcturus Therapeutics Holdings Inc.

NasdaqGM:ARCT Stock Report

Mkt Cap: US$546.8m

Arcturus Therapeutics Holdings Future Growth

How is Arcturus Therapeutics Holdings forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


63.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:ARCT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202531329-121-947
12/31/2024180-16-127-859
12/31/2023117-105-66-599
9/30/202252-147-176-171N/A
6/30/202241-165-150-145N/A
3/31/202215-198-147-141N/A
12/31/202112-204-138-135N/A
9/30/20219-196-102-99N/A
6/30/20219-163-100-98N/A
3/31/20219-119-76-74N/A
12/31/202010-72-45-43N/A
9/30/202010-52-45-44N/A
6/30/202011-38-32-31N/A
3/31/202019-29-14-13N/A
12/31/201921-26-7-6N/A
9/30/201925-16-5-5N/A
6/30/201926-13-9-9N/A
3/31/201918-22-27-26N/A
12/31/201816-22-22-21N/A
9/30/201810-26-11-10N/A
6/30/201810-25-6-5N/A
3/31/201812-1601N/A
12/31/201713-11-10N/A
12/31/201620-2-4-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ARCT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: ARCT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ARCT is expected to become profitable in the next 3 years.

Revenue vs Market: ARCT's revenue (40.1% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: ARCT's revenue (40.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ARCT is forecast to be unprofitable in 3 years.


Discover growth companies